Health & Medicine

6

Long Radiation Treatments Called Unnecessary in Many Breast Cancer Cases

December 10, 2014

New research about breast cancer treatment from the Perelman School of Medicine’s Justin Bekelman and Ezekiel Emanuel, also of the Whar

Article Source: New York Times
facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653December 10, 2014

Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation

Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicineresearchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660December 10, 2014

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

blurb: 
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659December 8, 2014

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

blurb: 
Findings Include Response Rates Over 90 Percent in Pediatric Acute Lymphoblastic Leukemia, and First Results of Non-Hodgkin Lymphoma Trial

The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194December 8, 2014

Penn Vet-Berkeley Study: New Therapy Holds Promise for Restoring Vision

A new chemical-genetic therapy restores light responses to the retinas of blind mice and dogs and enables the mice to guide their behavior according to visual cues, setting the stage for clinical trial in humans.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194December 8, 2014

The Women in Science Program at Penn Offers Cross-generational Wisdom

blurb: 
Ware College House’s Women in Science program, founded by Medicine’s Helen Davies, offers support and inspiration for budding scientists, both female and male.

By Madeleine Stone  @themadstone

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653December 3, 2014

Brain Activity after Smokers Quit Predicts Chances of Relapsing, Penn Medicine Study Suggests

Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today’s clinical or behavioral tools for assessing relapse risk.

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653December 4, 2014

People with Mental Illness More Likely To Be Tested for HIV, Penn Medicine Study Finds

People with mental illness are more likely to have been tested for HIV than those without mental illness, according to a 

Penn Researchers Identify ‘Nudge’ to Increase Generic Prescribing

November 26, 2014

Mitesh Patel of the Perelman School of Medicine comments on boosting the frequency of physicians prescribing generic br

Immunology: Oral Solutions

November 26, 2014

Henry Daniell of the School of Dental Medicine is featured for developing plant-based capsules.

Article Source: Nature.com